Xanadu signs agreements with Yale to support development of intranasal SARS-CoV-2 vaccine booster Feb. 9, 2022
Navidea sponsors research at Penn to evaluate Tc99m tilmanocept as prognostic marker in glioblastoma Feb. 8, 2022
Dyve and Moffitt collaborate to study buffering agent for transdermal delivery in cancer models Feb. 7, 2022
Parkinson's UK and Domainex collaborate to target neuroinflammation to slow Parkinson's disease Feb. 7, 2022
eTheRNA and Merck KGaA sign research agreement to assess mRNA technology for therapeutic vaccination Feb. 7, 2022
LISCure and Scripps collaborate on bacteria-mediated immuno-oncology candidates for cancer Feb. 4, 2022
Brickell licenses rights to Carna's STING antagonists for autoimmune and inflammatory diseases Feb. 3, 2022
RSS